Saturday, 14 December 2024
  
Login

Australia's most trusted
source of pharma news

Saturday, 14 December 2024
News

New shortage hits Pfizer drug

 Posted 28 November 2024 PM

A new anticipated shortage has hit Pfizer's PBS-listed high-strength Bicillin L-A antibiotic, with the TGA approving an overseas registered product available from this week to cover any potential supply gaps.

The company notified the regulator that an ongoing shortage of Bicillin L-A (benzathine benzylpenicillin tetrahydrate) 600,000 unit prefilled syringes for injection is estimated to continue until April 2025. It also flagged a new anticipated shortage of the high-strength Bicillin L-A 1.2 million unit prefilled syringes for injection from 20 December 2024 to 10 January 2025.

To see the whole article, please login

Popular

Is 2024 the Year of Burnout?
Albo puts hand up for pharma selfie
Why pharma redundancies hurt
Top specialist in Deep Fake scam
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2024 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home